Fatal fungemia with Scedosporium prolificans in a patient with acute myeloid leukemia

Medical Mycology Journal
Makoto NishimoriTakayuki Takahashi

Abstract

Scedosporium prolificans (S. prolificans) is a type of mold, which rarely affects immunocompromised people. We treated a 71-year-old woman with acute myeloid leukemia (AML-M5a) with low-dose cytarabine, acralubicin, and filgrastim as the induction therapy. On day 7 after the initiation of chemotherapy, she became febrile and agranulocytic, and developed anal pain ; therefore, we discontinued the chemotherapy on day 8. Broad-spectrum antibiotics, micafungin, and then liposomal amphotericin B were ineffective. The serum concentration of β-D-glucan was 525 pg/mL. She died of multiple organ failure on day 17. S. prolificans was detected from the blood culture on day 13. Physicians should consider Scedosporium spp. infection when principal antifungal agents are ineffective and fungal infection is strongly suspected.

References

Jan 1, 1990·The Journal of Infectious Diseases·C M WilsonI F Salkin
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shahid HusainNina Singh
Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gregory A LamarisDimitrios P Kontoyiannis
Jan 19, 2008·Clinical Microbiology Reviews·Karoll J CortezThomas J Walsh
Nov 26, 2008·Medical Mycology·Juan Luis Rodriguez-TudelaManuel Cuenca-Estrella
May 19, 2009·The Spine Journal : Official Journal of the North American Spine Society·Carolina Garcia-VidalPedro Fernandez-Viladrich
Jun 18, 2009·Spine·Francisco Javier Carod-ArtalMarco de Agassiz-Vasques
Apr 20, 2010·Pathology International·Masatomo KimuraKiyofumi Ohkusu
Dec 16, 2010·Internal Medicine Journal·M SpanevelloG A Kennedy
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Apr 2, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M L Fernandez GuerreroA Román
Aug 20, 2011·Annals of the Rheumatic Diseases·Takao KoikeHisashi Yamanaka
Mar 16, 2012·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Hisaaki NishioTakashi Saitoh
Feb 8, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·D M SayahL E Leard
Apr 23, 2013·Diagnostic Microbiology and Infectious Disease·Roberto ReinosoMargarita Calonge
Jan 1, 2010·Retinal Cases & Brief Reports·Thomas M OʼHearnDean Eliott

❮ Previous
Next ❯

Citations

Aug 2, 2017·Mycopathologia·Carsten SchwarzPeter James Barry
Mar 15, 2018·Medical Mycology·Carsten SchwarzUNKNOWN ECMM/ISHAM working group Fungal respiratory infections in Cystic Fibrosis (Fri-CF)
Mar 15, 2018·Medical Mycology·Andoni Ramirez-GarciaFernando L Hernando
Jun 25, 2016·American Journal of Hematology·Preetesh JainNaveen Pemmaraju

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.